Cargando…
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab
Migraine is the second cause of disability and of lost years of healthy life worldwide. Migraine is characterized by recurrent headache attacks and accompanying disabling symptoms lasting 4–48 h. In episodic migraine, attacks occur in less than 15 days per month and in chronic migraine, in more than...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465143/ https://www.ncbi.nlm.nih.gov/pubmed/34577624 http://dx.doi.org/10.3390/ph14090924 |